chr2-151663543-C-T
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong
The NM_001164508.2(NEB):c.5763+5G>A variant causes a splice region, intron change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000483 in 1,448,334 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_001164508.2 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NEB | NM_001164507.2 | c.5763+5G>A | splice_region_variant, intron_variant | Intron 45 of 181 | ENST00000427231.7 | NP_001157979.2 | ||
NEB | NM_001164508.2 | c.5763+5G>A | splice_region_variant, intron_variant | Intron 45 of 181 | ENST00000397345.8 | NP_001157980.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NEB | ENST00000397345.8 | c.5763+5G>A | splice_region_variant, intron_variant | Intron 45 of 181 | 5 | NM_001164508.2 | ENSP00000380505.3 | |||
NEB | ENST00000427231.7 | c.5763+5G>A | splice_region_variant, intron_variant | Intron 45 of 181 | 5 | NM_001164507.2 | ENSP00000416578.2 | |||
NEB | ENST00000409198.5 | c.5763+5G>A | splice_region_variant, intron_variant | Intron 45 of 149 | 5 | ENSP00000386259.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000821 AC: 2AN: 243460Hom.: 0 AF XY: 0.0000152 AC XY: 2AN XY: 131980
GnomAD4 exome AF: 0.00000483 AC: 7AN: 1448334Hom.: 0 Cov.: 31 AF XY: 0.00000696 AC XY: 5AN XY: 718022
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
NEB-related disorder Pathogenic:1Uncertain:1
The NEB c.5763+5G>A variant is predicted to interfere with splicing. This variant was reported together with second NEB variant in at least one individual with typical Nemaline myopathy (Table S1C, Lehtokari et al. 2014. PubMed ID: 25205138; patient E2, Table 1, Cummings et al. 2017. PubMed ID: 28424332). This variant is predicted to alter splicing based on available splicing prediction software (SpliceAI, Jaganathan et al. 2019. PubMed ID: 30661751). However, the use of computer prediction softwares is not equivalent to functional evidence. This variant is reported in 0.0034% of alleles in individuals of South Asian descent in gnomAD. Although we suspect that this variant may be pathogenic, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
PVS1, PM2, PM3 -
Nemaline myopathy 2 Pathogenic:1Uncertain:1
- -
For these reasons, this variant has been classified as Pathogenic. Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Studies have shown that this variant is associated with altered splicing resulting in unknown protein product impact (PMID: 28424332). This sequence change falls in intron 45 of the NEB gene. It does not directly change the encoded amino acid sequence of the NEB protein. It affects a nucleotide within the consensus splice site. This variant is present in population databases (rs776167256, gnomAD 0.003%). This variant has been observed in individual(s) with clinical features of nemaline myopathy (PMID: 25205138, 28424332; Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is also known as chr2:152520057C>T . ClinVar contains an entry for this variant (Variation ID: 552335). -
Nemaline myopathy Pathogenic:1
The c.5763+5G>A variant in NEB has been reported, in the compound heterozygous state, in one individual with nemaline myopathy (PMID: 25205138, 28424332), and has been identified in 0.002% (1/85046) of South Asian chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP ID: rs776167256). Although this variant has been seen in the general population in a heterozygous state, its frequency is low enough to be consistent with a recessive carrier frequency. This variant has also been reported in ClinVar (Variation ID: 552335) and has been interpreted as pathogenic by Invitae and as a variant of uncertain significance by Counsyl. This variant is located in the 3’ splice region. Computational tools do suggest an impact to splicing. However, this information is not predictive enough to determine pathogenicity. RNAseq analysis performed on affected tissue shows evidence of intron retention after exon 45 (PMID: 28424332). Loss of function of the NEB gene is an established disease mechanism in autosomal recessive nemaline myopathy. In summary, although additional studies are required to fully establish its clinical significance, this variant is likely pathogenic for autosomal recessive nemaline myopathy. ACMG/AMP Criteria applied: PM3, PVS1_strong, PM2_supporting (Richards 2015). -
Arthrogryposis multiplex congenita 6 Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at